491 results on '"Younes, Mamoun"'
Search Results
152. In Reply
153. Clinical Importance of Estrogen Receptor-β Evaluation in Breast Cancer Patients Treated With Adjuvant Tamoxifen Therapy
154. M1928 P53 Immunostaining Predicts Malignant Progression in Barrett's Metaplasia
155. M1938 The Significance of An Indefinite for Dysplasia Diagnosis in Patients with Barrett's Metaplasia
156. M1931 The Utility of Cytologic Diagnosis of Dysplasia in Patients with Barrett's Metaplasia
157. Decreased GLIPR1 Expression in Esophageal Adenocarcinoma
158. Enhanced survival in perineural invasion of pancreatic cancer: an in vitro approach
159. Atypical NK-cell Proliferation of the Gastrointestinal Tract in a Patient With Antigliadin Antibodies but not Celiac Disease
160. Functional expression of TRAIL receptors TRAIL-R1 and TRAIL-R2 in esophageal adenocarcinoma
161. Is the Incidence of Esophageal Adenocarcinomas in Patients With Barrett’s Esophagus Really Overestimated?
162. Goblet Cell Mimickers in Esophageal Biopsies Are Not Associated with an Increased Risk for Dysplasia
163. Comparison of Monoclonal Versus Polyclonal Calretinin Antibodies for Immunohistochemical Diagnosis of Malignant Mesothelioma
164. Differential Trends in the Intestinal and Diffuse Types of Gastric Carcinoma in the United States, 1973–2000: Increase in the Signet Ring Cell Type
165. 735: Differential Expression of Estrogen Receptor α and β in Bladder Cancer Cell Lines and Human Bladder Tumor Tissue
166. Expression of the High Mobility Group Proteins HMGI(Y) Correlates with Malignant Progression in Barrett’s Metaplasia
167. Can proton pump inhibitors be blamed for the rising incidence of esophageal cancer?
168. Expression of vascular endothelial growth factor receptor‐3 (VEGFR‐3) in human prostate
169. c-KitProto-Oncogene Product Is Rarely Detected in Colorectal Adenocarcinoma
170. P53 Protein and Malignant Progression in Barrett's Metaplasia (Barrett's Esophagus)
171. Expression of the high mobility group proteins HMGI(Y) correlates with malignant progression in Barrett metaplasia
172. RANK is expressed as a late event during malignant progression in Barrett's metaplasia
173. Detection of oxidative DNA damage (ODD) in esophageal biopsies of patients with reflux symptoms and normal pH monitoring studies
174. Expression of estrogen receptor beta (ER-B) isoforms in Barrett metaplasia, dysplasia, and esophageal adenocarcinoma
175. Response to Dr. Castell
176. Estrogen Receptor-Beta Expression in Hereditary Breast Cancer
177. Immunohistochemical detection of telomerase reverse transcriptase in colorectal adenocarcinoma and benign colonic mucosa
178. Is Immunostaining for Helicobacter pylori Superior to the Special Stain Thiazine in Detecting Small Numbers of H. pylori in Gastric Biopsies?
179. Glut3 Expression in Biopsy Specimens of Laryngeal Carcinoma Is Associated With Poor Survival
180. Expression of CD40 ligand (CD154) in B and T lymphocytes of Hodgkin disease
181. Estrogen receptor β is expressed in human colorectal adenocarcinoma
182. Photodynamic therapy and genetic abnormalities
183. Estrogen receptor beta expression in invasive breast cancer
184. Discrimination of inflammatory bowel disease using Raman spectroscopy and linear discriminant analysis methods
185. Decreased expression of fas (CD95/AP01)associated with goblet cell metaplasia in barrett's esophagus
186. Expression of tumor necrosis factor-related ap-optosis-inducing ligand (TRAIL) in human colorectal adenocarcinomas
187. The neutral amino acid transporter ASCT2 is overexpressed in human colorectal adenomas and carcinomas
188. Incidence and survival trends of esophageal carcinoma in the United States
189. Expression of the vascular endothelial growth factor receptor 3 (VEGFR-3/FLT4) in human colorectal adenocarcinoma
190. Estrogen receptor beta (ER-B) is expressed in human colorectal adenocarcinomas
191. Optimized Cyclin D1 Immunoperoxidase Staining in Mantle Cell Lymphoma
192. Overexpression of Fas ligand (FasL) during malignant transformation in the large bowel and in Barrett's metaplasia of the esophagus
193. Adult Mesoblastic Nephroma
194. Expression of the human erythrocyte glucose transporter Glut1 in cutaneous neoplasia
195. Absence of prognostic significance of bcl-2 immunopositivity in non-small cell lung cancer: Analysis of 427 cases
196. Analysis of p53 gene deletions in patients with non-Hodgkin's lymphoma by dual-colour fluorescencein-situhybridization
197. Transforming Growth Factor- ? Type II Receptor Is Infrequently Expressed in Human Breast Cancer
198. p53 protein accumulation in Barrett's metaplasia, dysplasia, and carcinoma: A follow-up study
199. Barrett's esophagus: histology and immunohistology.
200. Oestrogen receptor-β CA repeat polymorphism is associated with incidence of colorectal cancer among females.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.